Bank of America
TVRD

Bank of America’s Tvardi Therapeutics TVRD Stock Holding History

Bank of America’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-25,382
Closed -$109K – 7191
2025
Q4 		$109K Buy
25,382
+10,020
+65% +$89.8K ﹤0.01% 5591
2025
Q3 		$599K Sell
15,362
-1,723
-10% -$49.1K ﹤0.01% 5671
2025
Q2 		$399K Buy
17,085
+8,070
+90% +$191K ﹤0.01% 5840
2025
Q1 		$137K Buy
9,015
+8,875
+6,339% +$134K ﹤0.01% 6349
2024
Q4 		$2.56K Sell
140
-8,950
-98% -$97.4K ﹤0.01% 7175
2024
Q3 		$101K Sell
9,090
-4,179
-31% -$49K ﹤0.01% 6323
2024
Q2 		$123K Sell
13,269
-4,404
-25% -$105K ﹤0.01% 6154
2024
Q1 		$579K Sell
17,673
-239
-1% -$6.2K ﹤0.01% 5266
2023
Q4 		$479K Buy
17,912
+5,630
+46% +$233K ﹤0.01% 5529
2023
Q3 		$743K Sell
12,282
-10,211
-45% -$958K ﹤0.01% 5025
2023
Q2 		$2.29M Buy
22,493
+1,358
+6% +$187K ﹤0.01% 4107
2023
Q1 		$3.74M Buy
21,135
+2,500
+13% +$837K ﹤0.01% 3801
2022
Q4 		$7.21M Buy
18,635
+16,955
+1,009% +$6.44M ﹤0.01% 3006
2022
Q3 		$565K Buy
1,680
+702
+72% +$254K ﹤0.01% 5309
2022
Q2 		$321K Sell
978
-749
-43% -$263K ﹤0.01% 5750
2022
Q1 		$756K Sell
1,727
-781
-31% -$321K ﹤0.01% 5487
2021
Q4 		$1.1M Buy
2,508
+522
+26% +$262K ﹤0.01% 5145
2021
Q3 		$1.1M Sell
1,986
-3,501
-64% -$1.76M ﹤0.01% 4965
2021
Q2 		$2.82M Sell
5,487
-8,695
-61% -$5.51M ﹤0.01% 4037
2021
Q1 		$11.1M Sell
14,182
-1,561
-10% -$1.07M ﹤0.01% 2608
2020
Q4 		$8.57M Sell
15,743
-15,624
-50% -$8.19M ﹤0.01% 2626
2020
Q3 		$14.4M Buy
31,367
+3,436
+12% +$2M ﹤0.01% 1979
2020
Q2 		$17.2M Buy
27,931
+2,812
+11% +$1.55M ﹤0.01% 1732
2020
Q1 		$11.9M Buy
25,119
+13,408
+114% +$7.29M ﹤0.01% 1908
2019
Q4 		$6.79M Buy
11,711
+6,702
+134% +$4.7M ﹤0.01% 2948
2019
Q3 		$3.3M Sell
5,009
-1,039
-17% -$864K ﹤0.01% 3594
2019
Q2 		$4.68M Buy
6,048
+2,119
+54% +$1.49M ﹤0.01% 3309
2019
Q1 		$2.77M Buy
3,929
+3,098
+373% +$1.85M ﹤0.01% 3716
2018
Q4 		$388K Buy
831
+291
+54% +$188K ﹤0.01% 5102
2018
Q3 		$465K Sell
540
-1,166
-68% -$842K ﹤0.01% 5004
2018
Q2 		$1.18M Buy
1,706
+1,040
+156% +$529K ﹤0.01% 4373
2018
Q1 		$297K Sell
666
-43
-6% -$20.9K ﹤0.01% 5156
2017
Q4 		$312K Sell
709
-24
-3% -$10.9K ﹤0.01% 5202
2017
Q3 		$361K Buy
733
+368
+101% +$184K ﹤0.01% 5133
2017
Q2 		$202K Sell
365
-85
-19% -$53.9K ﹤0.01% 5295
2017
Q1 		$298K Sell
450
-48
-10% -$25.6K ﹤0.01% 5138
2016
Q4 		$166K Buy
498
+72
+17% +$23.1K ﹤0.01% 5406
2016
Q3 		$128K Buy
426
+52
+14% +$11.3K ﹤0.01% 5336
2016
Q2 		$65K Buy
374
+103
+38% +$22.4K ﹤0.01% 5721
2016
Q1 		$61K Sell
271
-184
-40% -$55K ﹤0.01% 5706
2015
Q4 		$276K Buy
455
+193
+74% +$106K ﹤0.01% 5171
2015
Q3 		$135K Sell
262
-2
-0.8% -$1.34K ﹤0.01% 5529
2015
Q2 		$115K Buy
264
+2
+0.8% +$773 ﹤0.01% 5523
2015
Q1 		$95K Sell
262
-42
-14% -$15.9K ﹤0.01% 5336
2014
Q4 		$109K Sell
304
-22
-7% -$7.08K ﹤0.01% 5817
2014
Q3 		$98K Buy
326
+235
+258% +$96.5K ﹤0.01% 6023
2014
Q2 		$56K Buy
+91
New +$49K ﹤0.01% 6574

Other funds holding TVRD

SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DWAM
Duncan Williams Asset Management Memphis, Tennessee $444M AUM 24.78% 1-Year Est. Return

Bank of America's TVRD Position: Q1 2026 in Review

Bank of America sold out of Tvardi Therapeutics (TVRD) in Q1 2026, closing a stake of 25,382 shares — an estimated $109K sold.

Bank of America first reported a position in TVRD in Q2 2014 and held it in 47 quarters. The position peaked at $17.2M in Q2 2020. 67 funds tracked by Wall St. Rank hold TVRD as of Q1 2026.

  • Bank of America reported no remaining Tvardi Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 25,382 Tvardi Therapeutics shares in Q1 2026, an estimated $109K.
  • Bank of America first reported a position in Tvardi Therapeutics in Q2 2014 and held it in 47 quarters.
  • Bank of America's Tvardi Therapeutics position peaked at $17.2M in Q2 2020.
  • 67 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.